Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea

Sep 20, 2023

Press releases

Evaxion Partners With Pharmaceutical Company Afrigen Biologics to Develop Novel mRNA Vaccine Against Gonorrhea

Evaxion announced a collaboration with Afrigen Biologics (Afrigen)

Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company 

Sep 18, 2023

Press releases

Evaxion expands preclinical bacterial vaccine pipeline in collaboration with leading pharmaceutical company 

Evaxion announced the initiation of a novel pipeline program, EVX-B3, an AI-designed vaccine candidate against an undisclosed bacterial pathogen.

Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development

Sep 11, 2023

Press releases

Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development

Evaxion has achieved a groundbreaking milestone in vaccine discovery with the validation of its AI-powered vaccine discovery platform, EDEN.

Evaxion announces Executive Management Changes to strengthen the AI-strategy

Aug 29, 2023

Press releases

Evaxion announces Executive Management Changes to strengthen the AI-strategy

Evaxion has hired a new Chief Executive Officer (“CEO”) to accelerate the strategic development and execution of the vast business opportunities at hand after having matured the Company’s AI platforms over the past 15 years.

Evaxion Announces Business Update and Second Quarter 2023 Financial Results

Aug 18, 2023

Press releases

Evaxion Announces Business Update and Second Quarter 2023 Financial Results

Evaxion today provided a business update and announced its second quarter 2023 financial results.

Evaxion announces financing commitments totaling up to USD 20 million with Global Growth Holding Limited

Aug 2, 2023

Press releases

Evaxion announces financing commitments totaling up to USD 20 million with Global Growth Holding Limited

Evaxion announced that it has entered into a binding agreement for a financing of up to USD 20 million with Global Growth Holding Limited (GGHL), a leading Dubai-based financial institution specialized in providing flexible equity-linked financings.

Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus 

Jul 31, 2023

Press releases

Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus 

Evaxion's presents promising results of EVX-B1 at the Staphylococcal Diseases Gordon Research Conference in New Hampshire, USA.

Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial

Jun 3, 2023

Press releases

Evaxion’s AI technology identifies cancer vaccine targets associated with longer progression-free survival of melanoma patients in the EVX-01 Phase 1 clinical trial

Evaxion's EVX-01 met its primary endpoints of safety and tolerability as positive clinical responses were reported. 

Evaxion Announces Business Update and First Quarter 2023 Financial Results

May 31, 2023

Press releases

Evaxion Announces Business Update and First Quarter 2023 Financial Results

Evaxion today announced its first quarter 2023 financial results and provided a business update.